Drug intelligence / Profile preview

(6S)-5-methyltetrahydrofolate dicholine

Development stage
Unknown
Lead developer
Balchem
Modality
Small Molecules
Administration
Oral
01

Overview

(6S)-5-Methyltetrahydrofolate dicholine is a highly water-soluble dicholine salt of levomefolate, the biologically active form of folate. Developed by Sensory Effects (a Balchem company) and marketed under the brand name Optifolin+®, it serves as a direct methyl donor in the folate metabolic pathway. Unlike synthetic folic acid, this compound bypasses the enzymatic reduction steps required by dihydrofolate reductase (DHFR), making it particularly effective for individuals with genetic polymorphisms in the MTHFR gene. It is primarily indicated for addressing folate deficiency and supporting folate status in women of childbearing age to prevent neural tube defects. Pharmacokinetic studies have demonstrated that the dicholine salt form possesses superior bioavailability and stability compared to traditional folic acid and other folate salts.

Brand names
Optifolin+
Other names
(6S)-5-methyltetrahydrofolate dicholinelevomefolate dicholineL-5-Methyltetrahydrofolate dicholineL5-Methyltetrahydrofolate dicholineL 5-Methyltetrahydrofolate dicholine
02

Targets

FOLR1 (FRα)MTR (Methionine synthase)SLC46A1 (Proton-coupled folate transporter)RFC1 (Reduced folate carrier type 1)

Beyond the preview

Go deeper on (6S)-5-methyltetrahydrofolate dicholine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (6S)-5-methyltetrahydrofolate dicholine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call